Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105536Phase 4Recruiting
Phase 4, randomised trial of dexibuprofen in Airways Infection and fever (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Difference in temperature change at 4 hours post-dose. Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105536.